B-Phage
PrivateTotal Funding Raised
$406,000
Company Overview
B-Phage is a biotechnology company developing AI-driven bacteriophage therapeutics to combat antimicrobial resistance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting, Data as a Service
AI Layer
Application
Keywords
phage therapybacteriophage therapeuticsantimicrobial resistanceAMRAI drug discoverysuperbug treatmentantibiotic alternativesdrug resistant infectionsphage discoveryphage-host matchingphage libraryprecision medicinebiorepositoryurinary tract infectionsUTIsE. coli treatment
Historical Pricing
Historical view of private secondary pricing and transaction trends.
B-Phage Comparables
Compare B-Phage with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phiogen | 84% | |
| PhageAI S.A. | 79% | |
| Tolka AI Therapeutics | 78% | |
B-Phage Funding Rounds
Historical fundraising activity
B-Phage Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OneBio Venture Studio | Pre Seed |
B-Phage Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about B-Phage's valuation, stock price, and market status.
See something wrong or outdated?